Quillaja Bark Extract is derived from the inner bark of the Soapbark tree (Quillaja saponaria Molina). As a naturally sourced plant-based surfactant rich in triterpene saponins, it plays an indispensable role as a foaming agent and emulsifier in the food and beverage industry, and is also increasingly being incorporated into the formulations of personal care products within the cosmetics sector. When used within approved food-grade limits, quillaja saponaria extract is considered safe; its safety profile has received scientific validation from regulatory bodies across numerous countries. However-as is the case with many active natural products-increased exposure risks (particularly through large-dose oral ingestion or parenteral administration) may pose potential safety hazards.
The Quillaja Saponaria Extract Powder produced by KINTAIBIO® strictly adheres to the relevant regulatory requirements established by both international and domestic authorities, thereby ensuring the safety and regulatory compliance of our products and laying a solid foundation for your global product development initiatives. Should you require specific formulation recommendations or samples for testing purposes, please feel free to contact us for further technical support and product documentation: sales@kintaibio.com.
The Scientific Basis for the Safety of Quillaja Bark Extract
Key Mechanisms Underlying the Low Oral Toxicity of Saponins
Gut microbiota can hydrolyze saponins into aglycones and sugars. Hemolytic saponins are unable to traverse the intestinal mucosa; this phenomenon may be attributed to the rapid clearance of small intestinal mucosal cells through the normal process of epithelial turnover. The low oral toxicity of saponins can also be ascribed to the vast surface area of the mammalian gastrointestinal tract, which effectively dilutes the concentration of ingested saponins. This mechanism explains why the same substance-which exhibits extremely high toxicity when administered intravenously or subcutaneously-demonstrates excellent tolerability and safety when ingested orally.
Empirical Evidence for the Oral Safety of Quillaja Saponaria Extract Powder
It is important to emphasize that the toxicity of food-grade Quillaja bark extract primarily restricts its use as an injectable adjuvant; however, when administered orally, this toxicity appears to be significantly attenuated. According to published studies, the acute oral LD₅₀ for mice is 1625 mg/kg of body weight; in the same literature, the acute LD₅₀ values for intravenous, intraperitoneal, and subcutaneous administration were reported as 275, 275, and 650 mg/kg of body weight, respectively.
Regarding long-term toxicity, a study involving rats fed a diet supplemented with 3.0% Quillaja bark extract for 108 weeks revealed no abnormalities in hematological or urinalysis parameters, nor was there any evidence of carcinogenicity. Similarly, a study involving TO-strain mice fed a diet supplemented with 1.5% Quillaja Saponaria Extract for 84 weeks revealed no histopathological changes; the No-Observed-Effect Level (NOEL) was established at 0.5% of the diet. In a 13-week repeated-dose study conducted on rats, the NOEL was determined to be 0.6% of the diet, with no histopathological changes observed that were attributable to the test substance.
Saponins: Natural Constituents of the Human Diet
Saponins are among the most ubiquitous constituents found in plants, occurring in over 500 different plant genera. These compounds occur naturally in various plants that are consumed by humans on a daily basis-such as potatoes, tomatoes, onions, legumes, tea, and certain herbs and spices-as well as in a number of crops used for animal feed. There have been no reports of adverse reproductive effects resulting from the ingestion of foods containing saponins; this further supports the safety assessment of soapbark extract at food-grade usage levels.
Evidence of the Non-mutagenicity of quillaja saponaria bark extract
Various mutagenicity studies provide additional corroboration for the safety of quillaja saponaria extract. In Salmonella bacterial gene mutation assays, several purified saponins extracted from alfalfa showed no significant increase in revertant colonies, either in the presence or absence of metabolic activation. Furthermore, numerous saponins isolated from a variety of plant sources demonstrated no mutagenic potential in Salmonella/microsome assays. Collectively, these results indicate that soapbark extract possesses no genotoxic potential.
Global Recognition of Quillaja Bark Extract by Authoritative Bodies
U.S. FDA: GRAS Determination and Regulatory Basis
The U.S. Food and Drug Administration (FDA) has designated Quillaja bark extract as a substance Generally Recognized as Safe (GRAS). 21 CFR 172.510 explicitly stipulates that Quillaja Saponaria Extract may be used as a food flavoring agent in various food categories. FEMA No. 2973 has been included in FEMA GRAS Publication No. 3. The FDA's EAFUS database lists the technical effects of Quillaja Saponaria Extract Powder as follows: emulsifier or emulsifying salt, flavor enhancer, flavoring agent or adjuvant, processing aid, propellant, and surface-finishing agent. Furthermore, GRAS notifications submitted in both 2005 and 2021 received "no objection" responses from the FDA.
It is important to emphasize that GRAS status and pre-market approval for food additives represent two distinct regulatory compliance pathways. The FDA explicitly states that a GRAS determination does not require pre-market approval; however, it must be substantiated by robust safety data and expert consensus.
EU EFSA: Authorization as E 999 and ADI Establishment
In the European Union, Quillaja bark extract has received official authorization under the food additive designation E 999. In 2019, the Panel on Food Additives and Flavourings (FAF Panel) of the European Food Safety Authority (EFSA) re-evaluated E 999 and established an Acceptable Daily Intake (ADI) of 3 mg saponins per kg of body weight per day. In 2024, EFSA issued a supplementary opinion regarding this re-evaluation, recommending amendments to the existing EU specifications-specifically, lowering the limits for lead, mercury, and arsenic; introducing maximum limits for cadmium and calcium oxalate; and expressing these limits on a saponin basis.
Additionally, in 2023 and 2024, EFSA evaluated the proposed extension of use for Quillaja Saponaria Extract Powder as an emulsifier in both solid and liquid food supplements. The Authority concluded that, should this new application be authorized, the established ADI would not be exceeded by any population group. This assessment further substantiates the safety of Quillaja Saponaria Extract when used in dosed food supplements.
JECFA: Assessment by the Joint FAO/WHO Expert Committee
The Joint FAO/WHO Expert Committee on Food Additives (JECFA) has also conducted a systematic assessment of this substance. In 2005, JECFA established a group Acceptable Daily Intake (ADI) for two specific types of quillaja saponaria extract-Type 1 and Type 2; notably, the ADI value established for Type 2 differs by an order of magnitude from the ADI established by EFSA. Users should adhere to the specific regulations applicable to the region where the product is intended to be marketed, and should consult the latest assessment opinions from both JECFA and EFSA to obtain the most accurate information.
Health Canada and Other Agencies
Health Canada has included quillaja saponaria extract powder in its List of Permitted Emulsifiers, Gelling Agents, Stabilizers, and Thickeners; furthermore, the Food Directorate of Health Canada has completed a detailed safety assessment of the substance.
Additionally, a pharmacopoeial monograph for Quillaja (soapbark) has been included in both the British and French Pharmacopoeias, further underscoring its traditional application and official recognition within the pharmaceutical sector.
Risk Boundaries of Quillaja Saponaria Extract : Dosage Determines Toxicity
Food-Grade Dosages: Safe And Reliable
When used as a foaming agent or emulsifier in approved, low concentrations within food products, Quillaja Saponaria Extract Powder is generally recognized as safe. The Acceptable Daily Intake (ADI) of 3 mg saponins per kg of body weight per day, established by the EFSA, serves as a widely referenced benchmark within global standards. In soft drinks, soapbark extract is utilized at concentrations reaching up to 200 mg/kg; it is also frequently added to human cough syrups. Both applications underscore its robust track record regarding clinical utility and consumer safety.
High Medicinal Dosages: Potential Safety Risks
However, the ingestion of large quantities may pose safety risks. Quillaja Saponaria Extract contains high levels of tannins; excessive intake can trigger gastrointestinal irritation, gastric discomfort, and potential damage to the kidneys or liver. Furthermore, the extract contains oxalates; high-dose ingestion may increase the risk of kidney stone formation-a concern that warrants particular caution among individuals with pre-existing kidney disease or a history of kidney stones.
Special Populations: Pregnancy and Lactation
Due to its high tannin and oxalate content, the consumption of Quillaja Saponaria Extract Powder at medicinal dosages during pregnancy is considered to carry potential safety risks, which may manifest as severe gastrointestinal distress or even lead to latent toxic reactions. Although the trace amounts of Quillaja Saponaria Bark Extract typically found in food or beverages are generally harmless, the ingestion of higher, medicinal dosages should nevertheless be avoided. Regulatory authorities worldwide uniformly advise pregnant and breastfeeding women to refrain from consuming medicinal dosages of Saponaria Extract.
Quillaja Saponaria Extract :Typical Applications and Usage Limits
Food and Beverages
In practical applications, the use of quillaja saponaria bark extract must strictly adhere to regulatory limits. The Acceptable Daily Intake (ADI) recommended by EFSA is 3 mg saponins per kg of body weight per day; this serves as a crucial benchmark for assessing the safety of cumulative exposure. In the United States, GRN 000165 proposes a maximum usage level of 500 mg/kg (on a dry-weight basis) in beverage concentrates, while GRN 000903 authorizes usage levels ranging from 30 to 185 mg/100g across a variety of food products.
Animal Feed
In the animal feed sector, the Scientific Opinion issued by the EU FEEDAP Panel concludes that, under the proposed conditions of use, quillaja saponaria extract powder is safe as a feed additive for the target species, consumers, and the environment. Specifically, it is deemed safe for broiler chickens at a level of 250 mg/kg of complete feed, with a safety margin of 20 (assuming the additive contains 3.58% saponins).
Veterinary Vaccine Adjuvants
In veterinary medicine, soapbark saponins exhibit immunostimulatory properties, and their primary application is as vaccine adjuvants. The adjuvant component consists of purified quillaja saponaria extract-a substance of uniform composition-commonly referred to as "Quil A." A typical dose for injectable vaccines contains 350 mg of saponins. Cattle, sheep, and pigs generally demonstrate good tolerance to subcutaneous injections of 1 mg of Quil A; adverse reactions are typically limited to mild soft-tissue swelling and a transient rise in body temperature, both of which typically resolve within two days. Furthermore, when saponins are administered via the Immunostimulating Complex (ISCOM) system, the hemolytic activity associated with the vaccine can be mitigated.
Quillaja Saponaria Extract :Industry Trends and Future Development Directions
Policy Drivers: The EU Ban on Antibiotics in Animal Feed
According to EU regulations, antimicrobial agents may not be used in animal production to promote growth or increase yield; furthermore, antimicrobial agents reserved for the treatment of human infections may not be used to treat animals. As a natural feed additive, quillaja saponaria extract powder has demonstrated efficacy in maintaining intestinal health and improving production performance in growing poultry, such as broilers. Consequently, as a natural feed additive serving as an alternative to antibiotics, it is expected to experience a significant surge in demand.
Market Size and Growth Trends
The global market for soapbark extract holds immense promise, presenting substantial growth opportunities across various sectors, including food and beverages, pharmaceuticals, personal care and cosmetics, and animal feed. Key factors driving this market growth include the ever-increasing demand for natural foaming agents, its expanding application in cosmetic formulations, and growing consumer preference for plant-derived ingredients. Regionally, Europe and the United States constitute the primary consumer markets for quillaja saponaria extract.
Future Directions for R&D
In the future, research and development efforts regarding organic quillaja saponaria extract are expected to continue expanding into two major domains: agriculture and pharmaceuticals. In the agricultural sector, quillaja saponaria extract powder holds broad research potential in the areas of fungal control and soil remediation; its inherent surfactant and antimicrobial properties warrant further in-depth development. In the pharmaceutical sector, purified fractions of soapbark saponins-particularly QS-21-have emerged as critical adjuvant components in various high-value vaccines (such as those for COVID-19, malaria, and shingles), with their safety and immunogenicity continuously being validated through human clinical trials.
where to buy Quillaja Saponaria Extract Powder?
Any assessment of safety is predicated upon reasonable usage and dosage. Quillaja Saponaria Extract Powder is considered safe when used within the authorized dosage limits for food and cosmetic applications; however, excessive ingestion or the use of unpurified preparations may pose safety risks. Saponaria bark contains high levels of tannins and oxalates; ingesting large quantities may lead to renal and hepatic damage, as well as gastrointestinal irritation. Consequently, the safe use of Quillaja Saponaria Extract relies not only on thorough evaluation by regulatory bodies but also on the collective adherence of all parties within the supply chain to established regulatory limits.
As a manufacturer of Saponaria bark extract powder, KINTAIBIO® remains committed to providing our customers with products that are safe, compliant, and fully traceable. We carefully select premium-quality raw Saponaria materials to ensure that saponin levels remain within a stable range. Furthermore, we control for impurities-such as pesticide residues, heavy metals, tannins, and oxalates-directly at the source, thereby guaranteeing the consistent quality of our products. We employ standardized extraction methods, followed by rigorous purification and refining processes, to ensure the purity and consistency of the final product. Additionally, we conduct strict, batch-by-batch testing for heavy metals, microbial contaminants, and physicochemical parameters to ensure that every single batch meets all regulatory requirements. Please contact us at sales@kintaibio.com.
